NAD(P)H: quinone oxidoreductase 1 (NQO1)- A viable biomarker in colorectal cancer

被引：0
|
作者：
Ganji, Chaithanya
Lakkakula, Bhaskar V. K.
Behera, Santosh Kumar
El-Rayes, Bassel F.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2169
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Genetic polymorphisms in the NAD(P)H: Quinone oxidoreductase (NQO1) gene locus.
    Gaedigk, A
    Tyndale, RF
    Jurima-Romet, M
    Sellers, EM
    Leeder, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 207 - 207
  • [22] The role of NAD(P)H:quinone oxidoreductase (NQO1) in redox regulation of pancreatic cancer cell growth
    Cullen, J
    Hinkhouse, M
    Gaut, A
    Liu, JR
    Weydert, C
    Domann, F
    Oberley, L
    GASTROENTEROLOGY, 2003, 124 (04) : A291 - A291
  • [23] NAD(P)H:Quinone Oxidoreductase 1 (NQO1) P187S Polymorphism and Prostate Cancer Risk in Caucasians
    Stoehr, Christine G.
    Nolte, Elke
    Wach, Sven
    Wieland, Wolf F.
    Hofstaedter, Ferdinand
    Hartmann, Arndt
    Stoehr, Robert
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (09) : 10959 - 10969
  • [24] NAD(P)H:quinone oxidoreductase 1 (NQO1):: chemoprotection, bioactivation, gene regulation and genetic polymorphisms
    Ross, D
    Kepa, JK
    Winski, SL
    Beall, HD
    Anwar, A
    Siegel, D
    CHEMICO-BIOLOGICAL INTERACTIONS, 2000, 129 (1-2) : 77 - 97
  • [25] Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer
    Ergen, H. Arzu
    Gormus, Uzay
    Narter, Fehmi
    Zeybek, Umit
    Bulgurcuoglu, Sibel
    Isbir, Turgay
    ANTICANCER RESEARCH, 2007, 27 (6B) : 4107 - 4110
  • [26] NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser Polymorphism and Colorectal Cancer Predisposition in the Ethnic Kashmiri Population
    Sameer, A. Syed
    Shah, Zaffar A.
    Syeed, Nidda
    Abdullah, Safiya
    Rasool, Roohi
    Afroze, Dil
    Siddiqi, Mushtaq A.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2010, 11 (01) : 209 - 213
  • [27] Protective role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in cisplatin-induced nephrotoxicity
    Gang, Gil-Tae
    Kim, Yong-Hoon
    Noh, Jung-Ran
    Kim, Kyoung-Shim
    Jung, Ju-Young
    Shong, Minho
    Hwang, Jung Hwan
    Lee, Chul-Ho
    TOXICOLOGY LETTERS, 2013, 221 (03) : 165 - 175
  • [28] Kinetics of NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibition by mitomycin C in vitro and in vivo
    Gustafson, DL
    Siegel, D
    Rastatter, JC
    Merz, AL
    Parpal, JC
    Kepa, JK
    Ross, D
    Long, ME
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (03): : 1079 - 1086
  • [29] NAD(P)H: Quinone oxidoreductase (NQO1) and catalase expression in nonseminomatous germ cell tumors
    Hashemi-Sadraei, Neda
    Adra, Nabil
    Kessler, Kenneth A.
    Idrees, Muhammad T.
    Einhorn, Lawrence
    Boothman, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [30] Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin
    Valerio, LG
    Kepa, JK
    Pickwell, GV
    Quattrochi, LC
    TOXICOLOGY LETTERS, 2001, 119 (01) : 49 - 57
12345